Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 41 results.
User Information
Export Records
  1. 1.   Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial
  2. Zaman, Khalequ; Schuind, Anne E; Adjei, Samuel; Antony, Kalpana; Aponte, John J; Buabeng, Patrick By; Qadri, Firdausi; Kemp,Troy; Hossain, Lokman; Pinto,Ligia; Sukraw, Kristen; Bhat, Niranjan; Agbenyega, Tsiri
  3. Vaccine. 2024, Apr 2; 42(9): 2290-2298.
  1. 2.   A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
  2. Zhang, Peng; Narayanan, Elisabeth; Liu, Qingbo; Tsybovsky, Yaroslav; Boswell, Kristin; Ding, Shilei; Hu, Zonghui; Follmann, Dean; Lin, Yin; Miao, Huiyi; Schmeisser, Hana; Rogers, Denise; Falcone, Samantha; Elbashir, Sayda M.; Presnyak, Vladimir; Bahl, Kapil; Prabhakaran, Madhu; Chen, Xuejun; Sarfo, Edward K.; Ambrozak, David R.; Gautam, Rajeev; Martin, Malcom A.; Swerczek, Joanna; Herbert, Richard; Weiss, Deborah; Misamore, Johnathan; Ciaramella, Giuseppe; Himansu, Sunny; Stewart-Jones, Guillaume; McDermott, Adrian; Koup, Richard A.; Mascola, John R.; Finzi, Andres; Carfi, Andrea; Fauci, Anthony S.; Lusso, Paolo
  3. Nature Medicine. 2021, Dec;
  1. 3.   Innate Immunity Modulating Impurities and the Immunotoxicity of Nanobiotechnology-Based Drug Products
  2. Holley,Claire; Dobrovolskaia,Marina
  3. MOLECULES. 2021, Dec; 26(23):
  1. 4.   An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide
  2. Holley,Claire; Cedrone,Edward; Donohue,Duncan; Neun,Barry; Verthelyi, Daniela; Pang, Eric S.; Dobrovolskaia, Marina A.
  3. Molecules. 2021, Dec; 26(24):
  1. 5.   Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines
  2. Nance,Kellie; Meier,Jordan
  3. ACS central science. 2021, May 26; 7(5): 748-756.
  1. 6.   Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
  2. Om, Kier; Paquin-Proulx, Dominic; Montero, Maria; Peachman, Kristina; Shen, Xiaoying; Wieczorek, Lindsay; Beck, Zoltan; Weiner, Joshua A.; Kim, Dohoon; Li, Yifan; Mdluli, Thembi; Shubin, Zhanna; Bryant, Christopher; Sharma, Vishakha; Tokarev, Andrey; Dawson, Peter; White, Yohann; Appelbe, Oliver; Klatt, Nichole R.; Tovanabutra, Sodsai; Estes, Jacob D.; Matyas, Gary R.; Ferrari, Guido; Alving, Carl R.; Tomaras, Georgia D.; Ackerman, Margaret E.; Michael, Nelson L.; Robb, Merlin L.; Polonis, Victoria; Rolland, Morgane; Eller, Michael A.; Rao, Mangala; Bolton, Diane L.
  3. PLOS PATHOGENS. 2020, SEP; 16(9): pii: e1008764.
  1. 7.   Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines
  2. Tsang, Sabrina H; Basu, Partha; Bender, Noemi; Herrero, Rolando; Kemp,Troy; Kreimer, Aimée R; Müller, Martin; Panicker, Gitika; Pawlita, Michael; Pinto,Ligia; Sampson, Joshua N; Sankaranarayanan, Rengaswamy; Schussler, John; Sehr, Peter; Sierra, Monica S; Unger, Elizabeth R; Waterboer, Tim; Hildesheim, Allan
  3. Vaccine. 2020, AUG 27; 38(38): pii: S0264-410X(20)30917-8.
  1. 8.   Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
  2. Ueda, George; Antanasijevic, Aleksandar; Fallas, Jorge A; Sheffler, William; Copps, Jeffrey; Ellis, Daniel; Hutchinson, Geoffrey B; Moyer, Adam; Yasmeen, Anila; Tsybovsky,Yaroslav; Park, Young-Jun; Bick, Matthew J; Sankaran, Banumathi; Gillespie, Rebecca A; Brouwer, Philip Jm; Zwart, Peter H; Veesler, David; Kanekiyo, Masaru; Graham, Barney S; Sanders, Rogier W; Moore, John P; Klasse, Per Johan; Ward, Andrew B; King, Neil P; Baker, David
  3. eLife. 2020, Aug 04; 9: pii: 9:e57659.
  1. 9.   Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial
  2. Stratton, Pamela; Battiwalla, Minoo; Tian, Xin; Abdelazim, Suzanne; Baird, Kristin; Barrett, A John; Cantilena, Caroline R; Childs, Richard W; DeJesus, Jessica; Fitzhugh, Courtney; Fowler, Daniel; Gea-Banacloche, Juan; Gress, Ronald E; Hickstein, Dennis; Hsieh, Matthew; Ito, Sawa; Kemp,Troy; Khachikyan, Izabella; Merideth, Melissa A; Pavletic, Steven Z; Quint, Wim; Schiffman, Mark; Scrivani, Claire; Shanis, Dana; Shenoy, Aarthi G; Struijk, Linda; Tisdale, John F; Wagner,Sarah; Williams, Kirsten M; Yu, Quan; Wood, Lauren V; Pinto, Ligia A
  3. JAMA oncology. 2020, MAY; 6(5): 696-705.
  1. 10.   Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine
  2. Matsuda, Kenta; Huang, Jinghe; Zhou, Tongqing; Sheng, Zizhang; Kang, Byong H.; Ishida, Elise; Griesman, Trevor; Stuccio, Sarah; Bolkhovitinov, Lyuba; Wohlbold, Teddy J.; Chromikova, Veronika; Cagigi, Alberto; Leung, Kwanyee; Andrews, Sarah; Cheung, Crystal S. F.; Pullano, Alyssa A.; Plyler, Jason; Soto, Cinque; Zhang, Baoshan; Yang, Yongping; Joyce, M. Gordon; Tsybovsky,Yaroslav; Wheatley, Adam; Narpala, Sandeep R.; Guo, Yicheng; Darko, Sam; Bailer, Robert T.; Poole, April; Liang, C. Jason; Smith, Jon; Alexander, Jeff; Gurwith, Marc; Migueles, Stephen A.; Koup, Richard A.; Golding, Hana; Khurana, Surender; McDermott, Adrian B.; Shapiro, Lawrence; Krammer, Florian; Kwong, Peter D.; Connors, Mark
  3. SCIENCE IMMUNOLOGY. 2019, Apr 19; 4(34):
  1. 11.   In Silico Methods in Antibody Design
  2. Zhao, Jun; Nussinov, Ruth; Wu, Wen-Jin; Ma, Buyong
  3. ANTIBODIES. 2018, Sep; 7(3):
  1. 12.   Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
  2. Pinto, Ligia; Dillner, Joakim; Beddows, Simon; Unger, Elizabeth R
  3. Vaccine. 2018, Aug 06; 36(32 Pt. A): 4792-4799.
  1. 13.   Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer
  2. Zhang, Peng; Gorman, Jason; Geng, Hui; Liu, Qingbo; Lin, Yin; Tsybovsky, Yaroslav; Go, Eden P; Dey, Barna; Andine, Tsion; Kwon, Alice; Patel, Mit; Gururani, Deepali; Uddin, Ferzan; Guzzo, Christina; Cimbro, Raffaello; Miao, Huiyi; McKee, Krisha; Chuang, Gwo-Yu; Martin, Loïc; Sironi, Francesca; Malnati, Mauro S; Desaire, Heather; Berger, Edward A; Mascola, John R; Dolan, Michael A; Kwong, Peter D; Lusso, Paolo
  3. Cell Host & Microbe. 2018, Jun 13; 23(6): 832-844.e6.
  1. 14.   Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens
  2. Georgiev, Ivelin S.; Joyce, Michael Gordon; Chen, Rita E.; Leung, Kwanyee; McKee, Krisha; Druz, Aliaksandr; Van Galen, Joseph G.; Kanekiyo, Masaru; Tsybovsky, Yaroslav; Yang, Eun Sung; Yang, Yongping; Acharya, Priyamvada; Pancera, Marie; Thomas, Paul V.; Wanninger, Timothy; Yassine, Hadi M.; Baxa, Ulrich; Doria-Rose, Nicole A.; Cheng, Cheng; Graham, Barney S.; Mascola, John R.; Kwong, Peter D.
  3. ACS INFECTIOUS DISEASES. 2018, May 11; 4(5): 788-796.
  1. 15.   Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo
  2. Mazor, Ronit; Crown, Devorah; Addissie, Selamawit; Jang, Youjin; Kaplan, Gilad; Pastan, Ira
  3. CELLULAR & MOLECULAR IMMUNOLOGY. 2017, 2017-05-01; 14(5): 432-442.
  1. 16.   Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
  2. Zhou, Tongqing; Doria-Rose, Nicole A; Cheng, Cheng; Stewart-Jones, Guillaume B E; Chuang, Gwo-Yu; Chambers, Michael; Druz, Aliaksandr; Geng, Hui; McKee, Krisha; Kwon, Young Do; O'Dell, Sijy; Sastry, Mallika; Schmidt, Stephen D; Xu, Kai; Chen, Lei; Chen, Rita E; Louder, Mark K; Pancera, Marie; Wanninger, Timothy G; Zhang, Baoshan; Zheng, Anqi; Farney, S Katie; Foulds, Kathryn E; Georgiev, Ivelin S; Joyce, M Gordon; Lemmin, Thomas; Narpala, Sandeep; Rawi, Reda; Soto, Cinque; Todd, John-Paul; Shen, Chen-Hsiang; Tsybovsky, Yaroslav; Yang, Yongping; Zhao, Peng; Haynes, Barton F; Stamatatos, Leonidas; Tiemeyer, Michael; Wells, Lance; Scorpio, Diana G; Shapiro, Lawrence; McDermott, Adrian B; Mascola, John R; Kwong, Peter D
  3. Cell Reports. 2017, Apr 25; 19(4): 719-732.
  1. 17.   SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
  2. Lai, L. L.; Kwa, S. F.; Kozlowski, P. A.; Montefiori, D. C.; Nolen, T. L.; Hudgens, M. G.; Johnson, W. E.; Ferrari, G.; Hirsch, V. M.; Felber, B. K.; Pavlakis, G. N.; Earl, P. L.; Moss, B.; Amara, R. R.; Robinson, H. L.
  3. Vaccine. 2012, Feb; 30(9): 1737-1745.
  1. 18.   A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
  2. Ledgerwood, J. E.; Pierson, T. C.; Hubka, S. A.; Desai, N.; Rucker, S.; Gordon, I. J.; Enama, M. E.; Nelson, S.; Nason, M.; Gu, W. J.; Bundrant, N.; Koup, R. A.; Bailer, R. T.; Mascola, J. R.; Nabel, G. J.; Graham, B. S.; Team, V. R. C. S.
  3. Journal of Infectious Diseases. 2011, May; 203(10): 1396-1404.
  1. 19.   Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
  2. Ho, J.; Moir, S.; Wang, W.; Posada, J. G.; Gu, W. J.; Rehman, M. T.; Dewar, R.; Kovacs, C.; Sneller, M. C.; Chun, T. W.; Follmann, D. A.; Fauci, A. S.
  3. Aids. 2011, Jan; 25(3): 295-302.
  1. 20.   Multiplex cytokine analysis technologies
  2. Lash, G. E.; Pinto, L. A.
  3. Expert Review of Vaccines. 2010, Oct; 9(10): 1231-1237.
  1. 21.   Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys
  2. Zielinski, R. J.; Smedley, J. V.; Perera, P. Y.; Silvera, P. M.; Waldmann, T. A.; Capala, J.; Perera, L. P.
  3. Vaccine. 2010, Oct; 28(43): 7081-7091.
  1. 22.   Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization
  2. Patel, V.; Valentin, A.; Kulkarni, V.; Rosati, M.; Bergamaschi, C.; Jalah, R.; Alicea, C.; Minang, J. T.; Trivett, M. T.; Ohlen, C.; Zhao, J.; Robert-Guroff, M.; Khan, A. S.; Draghia-Akli, R.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2010, Jul; 28(30): 4827-4836.
  1. 23.   Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
  2. Chen, W. Z.; Zhu, Z. Y.; Liao, H. X.; Quinnan, G. V.; Broder, C. C.; Haynes, B. F.; Dimitrov, D. S.
  3. Viruses-Basel. 2010, Feb; 2(2): 547-565.
  1. 24.   Two-Step Synthesis of Galactosylated Human Serum Albumin as a Targeted Optical Imaging Agent for Peritoneal Carcinomatosis
  2. Regino, C. A. S.; Ogawa, M.; Alford, R.; Wong, K. J.; Kosaka, N.; Williams, M.; Feild, B. J.; Takahashi, M.; Choyke, P. L.; Kobayashi, H.
  3. Journal of Medicinal Chemistry. 2010, Feb; 53(4): 1579-1586.
  1. 25.   Temporal characteristics of botulinum neurotoxin therapy
  2. Lebeda, F. J.; Cer, R. Z.; Stephens, R. M.; Mudunuri, U.
  3. Expert Review of Neurotherapeutics. 2010, Jan; 10(1): 93-103.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel